Metabolic Bone Disease in Gastrointestinal Illness

Gastroenterology Clinics of North America

Volumn 36, Issue 1, 2007, Pages 161-190

  Williams, Susan E ^a   Seidner, Douglas L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALENDRONATE SODIUM PLUS VITAMIN D3; ALENDRONIC ACID; CAFFEINE; CALCIUM CARBONATE; COLECALCIFEROL; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYANOCOBALAMIN; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; FEMHRT; FOSAMAX PLUS D; GLUCOCORTICOID; IBANDRONIC ACID; MAGNESIUM; METHOTREXATE; PARATHYROID HORMONE[1-34]; PHOSPHORUS; PROTEIN; RALOXIFENE; RETINOL; RISEDRONATE SODIUM PLUS CALCIUM CARBONATE; RISEDRONIC ACID; SALCATONIN; SODIUM; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN K GROUP;

ACHLORHYDRIA; BARIATRIC SURGERY; BONE DENSITY; CALCIUM TRANSPORT; CELIAC DISEASE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; GASTRECTOMY; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE GRAFT; LACTASE DEFICIENCY; LIVER DISEASE; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALABSORPTION; METABOLIC BONE DISEASE; NUTRITIONAL ASSESSMENT; OSTEODYSTROPHY; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PARENTERAL NUTRITION; PROTEIN CALORIE MALNUTRITION; REVIEW; RISK FACTOR; UNITED STATES;

BARIATRIC SURGERY; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; GASTRECTOMY; GASTROINTESTINAL DISEASES; HUMANS; LIVER DISEASES; NUTRITION DISORDERS;

EID: 34247469322     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.01.005     Document Type: Review

References (120)

1. Dennisson E. Osteoporosis. In: Pinchera A., Bertagna X., and Fischer J. (Eds). Endocrinology and metabolism (2001), McGraw-Hill International (UK), London 271-282
2. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/physguide. Accessed October 21, 2006.
3. Skugor M, Licata A. The Cleveland Clinic Disease Management Project: osteoporosis. The Cleveland Clinic Foundation. Available at: http://www.clevelandclinicmeded.com/diseasemanagement/2005. Accessed October 21, 2006.
4. Bernstein C.N., Leslie W.D., and Leboff M. AGA technical review: osteoporosis in gastrointestinal diseases. Gastroenterology 124 3 (2003) 795-841
5. Shoback D., Marcus R., and Bilke D. Metabolic bone disease. In: Greenspan F.S., and Gardner D.G. (Eds). Basic and clinical endocrinology. 7th edition (2004), McGraw-Hill, New York 295-361
6. Weaver C.M., Heaney R.P., et al. Calcium. In: Shils M.E., Olsen J.A., and Shine M. (Eds). Modern nutrition in health and disease. 9th edition (1999), Lippincott Williams & Wilkins, Philadelphia 141-155
7. National Osteoporosis Foundation. The many faces of secondary osteoporosis. Osteoporosis Clinical Updates vol. III 3 (2002) p. 2-7
8. Obermayer-Pietsch B.M., Bonelli C.M., Walter D.E., et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 19 1 (2004) 42-47
9. Sanchez A.J., and Aranda-Michel J. Liver disease and osteoporosis. Nutr Clin Pract 21 (2006) 273-278
10. Cohen A., Ebeling P., Sprague S., et al. Transplantation osteoporosis. In: Favus M. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th edition (2006), American Society for Bone and Mineral Research, Washington, DC 302-309
11. Fryer J.P. Intestinal transplant: an update. Curr Opin Gastroenterol 21 2 (2005) 162-168
12. Licata A.A. Osteoporosis in men: suspect secondary disease first. Cleve Clin J Med 70 3 (2003) 247-254
13. Fiore C.E., Pennisi P., Ferro G., et al. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm Metab Res 38 (2006) 417-422
14. Mason E.M., Jalagani H., and Vinik A.I. Metabolic complications of bariatric surgery: diagnosis and management issues. Gastroenterol Clin North Am 34 (2006) 25-33
15. Cijevschi C., Mihai C., Zbranca E., et al. Osteoporosis in liver cirrhosis. Rom J Gastroenterol 14 4 (2005) 337-341
16. Licata A. Diagnosing primary osteoporosis: it's more than a T score. Cleve Clin J Med 73 5 (2006) 473-476
17. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal disease. Gastroenterology 124 3 (2003) 791-794
18. Lichtenstein G.R., Sands B.E., and Paziansa M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 12 8 (2006) 797-813
19. Nightingale J.M.D. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterology 17 6 (2003) 907-929
20. U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General (2004), U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville (MD) p. 166-70
21. Higdon J. Manganese (2001), Linus Pauling Institute, Oregon State University. http://lpi.oregonstate.edu Accessed October 24, 2006
22. Higdon J. Lignans (2005), Linus Pauling Institute, Oregon State University. http://lpi.oregonstate.edu Accessed October 26, 2006
23. Ilich J.Z., and Kerstetter J.E. Nutrition in bone health revisited: a story beyond calcium. J Am Coll Nutr 19 6 (2000) 715-737
24. Maggio D., Polidori M.C., and Barabani M. Low levels of carotenoids and retinol in involutional osteoporosis. Bone 38 (2006) 244-248
25. Marie J.P., Ammann P., Boivin G., et al. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69 (2001) 121-129
26. National Academy of Sciences Executive Summary: dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC. 1997. Available at: http://niams.nih.gov.
27. National Institutes of Health Osteoporosis and Related Bone Diseases-National Resource Center. Health topics: other nutrients and bone health. Bethesda (MD). 2004.
28. National Institutes of Health Osteoporosis and Related Bone Diseases-National Resource Center. Health topics: phytoestrogens and bone health. Bethesda (MD). 2005.
29. National Osteoporosis Foundation. Over-the-counter products and osteoporosis: case discussions. Osteoporosis Clinical Updates vol. III 2 (2002) p. 1-7
30. Penniston K.L., and Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 83 (2006) 191-201
31. Gueguen L., and Oiubtukkart A. The bioavailability of dietary calcium. J Am Coll Nutr 19 2 (2000) 119S-136S
32. Holick M.F., and Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus M.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th edition (2006), American Society for Bone and Mineral Research, Washington, DC 106-114
33. National Institute of arthritis and musculoskeletal and skin diseases. Medications to prevent and treat osteoporosis. Available at:http://www.niams.nih.gov/. Accessed October 26, 2006.
34. National Osteoporosis Foundation. Pharmacologic options (2005 update). In: Physician's guide to prevention and treatment of osteoporosis. Washington, DC; National Osteoporosis Foundation: 1998.
35. Chines A., and Pacifici R. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int 47 5 (1990) 291-295
36. Neumann L., and Jensen B.G. Osteomalacia from Al and Mg antacids. Report of a case of bilateral hip fracture. Acta Orthop Scand 60 3 (1989) 361-362
37. Recker R.R. Calcium absorption and achlorhydria. N Engl J Med 313 (1985) 70-73
38. Drinka P.J., Moore J., and Boushon M.C. Severe hypercalcemia after transition from calcium carbonate to calcium citrate in an elderly woman treated with ergocalciferol 50,000 IU per day. Am J Geriatr Pharmacother 4 (2006) 70-74
39. Newcomer A.D., Hodgson S.F., McGill D.B., et al. Lactase deficiency: prevalence in osteoporosis. Ann Intern Med 89 2 (1978) 218-220
40. Carlin A.M., Rao D.S., Meslemani A.M., et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Rel Dis 2 2 (2006) 98-103
41. Puzziferri N., Blankenship J., and Wolfe B.M. Surgical treatment for obesity. Endocrine 29 1 (2006) 11-19
42. Hamoui N., Anthone G., and Crookes F. Calcium metabolism in the morbidly obese. Obes Surg 14 1 (2004) 9-12
43. Newbery L., Dolan K., Hatzifotis M., et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 13 6 (2003) 893-895
44. Haria D.M., Sibonga J.D., and Taylor H.C. Hypocalcemia, hypovitaminosis D osteopathy, osteopenia, and secondary hyperparathyroidism 32 years after jejunoileal bypass. Endocr Pract 11 5 (2005) 335-340
45. Goldner W.S., O'Dorisio T.M., Dillon J.S., et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 12 (2002) 685-692
46. De Prisco C., and Levine S.N. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 329 (2005) 57-61
47. Atreja A., Abacan C., and Licata A. A 51-year-old woman with debilitating cramps 12 years after bariatric surgery. Cleve Clin J Med 70 (2003) 417-426
48. Collazo-Clavell M.L., Jimenez A., Hodgson S.F., et al. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 10 (2004) 287-288
49. Hensrud D.D., and McMahon M.M. Bariatric surgery in adults with extreme (not morbid) obesity. Mayo Clin Proc 81 10 Suppl (2006) S3-S4
50. McGlinch B.P., Que F.G., Nelson J.L., et al. Perioperative care of patients undergoing bariatric surgery. Mayo Clin Proc 81 10 Suppl (2006) S25-S33
51. Brethauer S.A., Chand C., and Schauer P.R. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med 73 11 (2006) 993-1007
52. Klaus J., Brueckel J., Steinkamp M., et al. High prevalence of vertebral fractures in patients with Crohn's disease. Gut 51 (2002) 654-658
53. von Tirpitz C., and Reinshagen M. Management of osteoporosis in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 15 8 (2003) 869-876
54. Lashner B. Inflammatory bowel disease. The Cleveland Clinic Disease Management Project. The Cleveland Clinic Foundation. Available at: http://www.clevelandclinicmeded.com/diseasemanagement/2005. Accessed October 21, 2006.
55. Lee S.K., and Green P.H.R. Celiac sprue (the great modern-day imposter). Curr Opin Rheumatol 18 (2006) 101-107
56. Vasquez H., Mazure R., Gonzalez D., et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 95 1 (2000) 183-189
57. Sanders D.S., Patel D., Khan F.B., et al. Case-finding for adult celiac disease in patients with reduced bone mineral density. Dig Dis Sci 50 3 (2005) 587-592
58. Lewis N.R., and Scott B.B. Should patients with celiac disease have their bone mineral density measured?. Eur J Gastroenterol Hepatol 17 (2005) 1065-1070
59. Kemppainen T., Kroger H., Janatuinen E., et al. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 25 (1999) 355-360
60. Bianchi M.L., and Bardella M.T. Bone and celiac disease. Calcif Tissue Int 71 (2002) 465-471
61. Pazianas M., Butcher G.P., Subhani M.J., et al. Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake. Osteoporos Int 16 (2005) 56-63
62. DiCecco S.R., and Francisco-Zeller N. Nutrition in alcoholic liver disease. Nutr Clin Pract 21 (2006) 245-254
63. Monegal A., Navasa M., Guanabens N., et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12 6 (2001) 484-492
64. Ramsey-Goldman R., Dunn J.E., Dunlop D.D., et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14 (1999) 456-463
65. Ninkovic M., Skingle S.J., Bearcroft P.W., et al. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12 8 (2000) 931-933
66. Cohen A., Sambrook P., and Shane E. Management of bone loss after organ transplantation. J Bone Miner Res 19 (2004) 1919-1932
67. Abu-Elmagd K.M. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 130 (2006) S132-S137
68. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta analysis. Arch Intern Med 159 (1999) 941-955
69. Cino M., and Greenberg G.R. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 97 4 (2002) 915-921
70. Schoon E.J., Bollani S., Mills P.R., et al. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol 3 (2005) 113-121
71. O'Regan S., Melhorn D.R., and Newman A.J. Methotrexate induced bone pain in childhood leukemia. Am J Dis Child 126 (1973) 448-450
72. Ragab A.H., Fresh R.S., and Vietti T.J. Osteoporosis fractures secondary to methotrexate therapy of leukemia in remission. Cancer 25 (1970) 580-585
73. Pfeilschifter J., and Diel I.J. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 28 (2000) 1570-1593
74. May K.P., West S.G., and McDermott M.T. The effect of low dose methotrexate on bone metabolism and histomorphology in rats. Arthritis Rheum 37 (1994) 201-206
75. Wheeler D.L., Vander Griend R.A., Wronski T.J., et al. The short and long-term effects of methotrexate on the rat skeleton. Bone 16 (1995) 215-221
76. Carbone L.D., Kaeley G., McKown K.M., et al. Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64 (1999) 100-101
77. Di Munno O., Mazzantini M., Sinigaglia L., et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 31 (2004) 1305-1309
78. Minaur N.J., Kounali S.V., Compston J.E., et al. Methotrexate in the treatment of rheumatoid arthritis: II. In vivo effects on bone mineral density. Br J Rheumatol 41 (2002) 741-749
79. McClave S. Critical care nutrition: getting involved as a gastrointestinal endoscopist. J Clin Gastroenterol 40 10 (2006) 870-890
80. Taylor S.J., Fettes S.B., Jewkes C., et al. Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury. Crit Care Med 27 11 (1999) 2525-2531
81. Cohen-Solal M., Baudoin C., Joly F., et al. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res 18 11 (2003) 1989-1994
82. Hise M.E., Compher C., Harlan L., et al. Inflammatory mediators and immune function are altered in home parenteral nutrition patients. Nutrition 22 (2006) 97-103
83. Seidner D.L., and Licata A. Parenteral nutrition-associated metabolic bone disease: pathophysiology, evaluation, and treatment. Nutr Clin Pract 15 (2000) 163-170
84. Haderslev K.V., Tjellesen L., Haderslev P.H., et al. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 28 5 (2004) 289-294
85. Raman M., Aghdassi E., Baum M., et al. Metabolic bone disease in patients receiving home parenteral nutrition: a Canadian study and review. JPEN J Parenter Enteral Nutr 30 6 (2006) 492-496
86. Seidner D.L. Parenteral nutrition-associated metabolic bone disease. JPEN J Parenter Enteral Nutr 26 (2002) S37-S42
87. 2) as a vitamin supplement. Am J Clin Nutr 84 (2006) 694-697
88. Huang Z., Himes J.H., and McGovern P.G. Nutrition and subsequent hip fracture risk among a national cohort of white women. Am J Epidemiol 144 (1996) 124-134
89. Feskanich D., Willett W.C., Stampfer M.J., et al. Protein consumption and bone fractures in women. Am J Epidemiol 143 (1996) 472-479
90. Rizzoli R., Ammann P., Chevalley T., et al. Protein intake and bone disorders in the elderly. Joint Bone Spine 68 (2001) 383-392
91. Greenspan S.L., and Resnick N.M. Geriatric endocrinology. In: Greenspan F.S., and Gardner D.G. (Eds). Basic and clinical endocrinology. 7th edition (2004), McGraw-Hill, New York 842-866
92. Rizzoli R., and Bonjour J.P. Dietary protein and bone health. J Bone Miner Res 19 4 (2004) 527-531
93. Kerstetter J., Svastisalee C., Caseria D., et al. A threshold for low-protein-diet-induced elevations in parathyroid hormone. Am J Clin Nutr 72 (2000) 168-173
94. Giannini S., Nobile M., Sartori L., et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69 (1999) 267-271
95. Krejs G.J., Nicar M.J., Zerwekh J.E., et al. Effect of 1, 25-dihydroxyvitamin D on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med 75 (1983) 973-981
96. Heaney R.P. Calcium, dairy products and osteoporosis. J Am Coll Nutr 19 (2000) 83S-99S
97. Shils M.E., et al. Magnesium. In: Shils M.E., Olsen J.A., and Shine M. (Eds). Modern nutrition in health and disease. 9th edition (1999), Lippincott Williams & Wilkins, Philadelphia 169-192
98. Nightingale J.M.D., and Woodward J.M. Guidelines for management of patients with a short bowel. Gut 55 (2006) 1-12
99. Stendig-Lindenberg G., Tepper R., and Leicher I. Trabecular bone density in a two year controlled trial of personal magnesium in osteoporosis. Magnes Res (1993) 155-163
100. 12 is associated with lower BMD: the Framingham osteoporosis study. J Bone Miner Res 20 1 (2005) 152-158
101. Weir D.G., Scott J.W., et al. Vitamin B12 Cobalamin. In: Shils M.E., Olsen J.A., and Shine M. (Eds). Modern nutrition in health and disease. 9th edition (1999), Lippincott Williams & Wilkins, Philadelphia 447-458
102. Goerss J.B., Kim C.H., Atkinson E.J., et al. Risk of fractures in patients with pernicious anemia. J Bone Miner Res 7 (1992) 573-579
103. Eastell R., Vieira N.E., Yergey A.L., et al. Pernicious anemia is a risk factor for osteoporosis. Clin Sci 82 (1992) 681-685
104. Laine L., Ahnen D., McClain C., et al. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14 (2000) 651-668
105. Holick M.F., et al. Vitamin D. In: Shils M.E., Olsen J.A., and Shine M. (Eds). Modern nutrition in health and disease. 9th edition (1999), Lippincott Williams & Wilkins, Philadelphia 329-346
106. Rosen C.J. Vitamin D and bone health in adults and the elderly. In: Holick M.F. (Ed). Vitamin D: physiology, molecular biology, and clinical applications (1999), Humana Press, Totowa (NJ) 287-306
107. Turner R.T. Skeletal response to alcohol. Alcohol Clin Exp Res 24 (2000) 1693-1701
108. Chakkalakal D.A. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 29 12 (2005) 2077-2090
109. Rapuri P.B., Gallagher J.C., and Kinyamu H.K. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74 (2001) 694-700
110. Harris S.S., and Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 60 (1994) 573-578
111. Massey L.K. Is caffeine a risk factor for bone loss in the elderly?. Am J Clin Nutr 74 (2001) 569-570
112. Knochel J.P., et al. Phosphorus. In: Shils M.E., Olsen J.A., and Shine M. (Eds). Modern nutrition in health and disease. 9th edition (1999), Lippincott Williams & Wilkins, Philadelphia 157-168
113. Heaney R.P., and Nordin B.E.C. Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis. J Am Coll Nutr 21 3 (2002) 239-244
114. Munger R.G., Cerhan J.R., and Chiu B.C. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women. Am J Clin Nutr 69 (1999) 147-152
115. Weikert C., Walter D., Hoffmann K., et al. The relation between dietary protein, calcium and bone health in women: results from the EPIC-Potsdam cohort. Ann Nutr Metab 49 (2005) 312-318
116. Whiting S.J., Boyle J.L., and Thompson A. Dietary protein, phosphorus and potassium are beneficial to bone mineral density in adult men consuming adequate dietary calcium. J Am Coll Nutr 21 (2002) 402-409
117. Teegarden D., Lyle R.M., McCabe G.P., et al. Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr 68 (1998) 749-754
118. Teucher B., and Fairweather-Tait S. Dietary sodium as a risk factor for osteoporosis: where is the evidence?. Proc Nutr Soc 62 (2003) 859-866
119. Harrington M., and Cashman K.D. High salt intake appears to increase bone resorption in postmenopausal women but high potassium intake ameliorates this adverse effect. Nutr Rev 61 5 (2003) 179-183
120. Scientific Advisory Committee on Nutrition: report on salt and health. Available at: http://www.sacn.gov.uk2003. Accessed November 4, 2006.